GLIMBELL-PM2

Description

This triple-combination tablet effectively manages Type 2 Diabetes Mellitus by combining three complementary mechanisms of action—insulin stimulation, insulin sensitivity enhancement, and glucose reduction. It is designed for patients requiring better glycemic control when monotherapy or dual therapy is insufficient.

Composition & Benefits:

• Glimepiride (2 mg): A sulfonylurea that stimulates the pancreas to produce more insulin, helping to lower blood sugar levels.

• Pioglitazone (15 mg): A thiazolidinedione that increases insulin sensitivity in muscle and fat tissues while decreasing hepatic glucose production.

• Metformin Hydrochloride (500 mg): A biguanide that reduces glucose absorption and improves insulin response, decreasing overall blood sugar levels.

Indications:

• Type 2 Diabetes Mellitus management when diet, exercise, and dual therapy fail to achieve glycemic control.

• Suitable for patients requiring a triple-drug regimen for better glucose management.

Dosage & Administration:

• Dosage: One tablet once or twice daily, as prescribed by a healthcare professional.

• Route: Oral, to be taken with food to minimize gastrointestinal side effects.

• Storage: Store in a cool, dry place below 25°C, away from moisture and direct sunlight.

Possible Side Effects:

• Hypoglycemia (low blood sugar)

• Weight gain (due to Pioglitazone)

• Gastrointestinal discomfort (nausea, bloating)

• Dizziness or fatigue

👉 Consult a doctor if side effects occur or persist.